No Picture
News

SK Inc., the Second Largest Conglomerate in South Korea, has invested $350 million in the Center for Breakthrough Medicines

KING OF PRUSSIA, Pa.: KING OF PRUSSIA, Pa., Jan. 10, 2022 /PRNewswire/ — The Center for Breakthrough Medicines (CBM) announced today that it has received $350 million in equity financing from SK Inc. (KRX: 034730) […]

No Picture
News

SaniSure Announces the Acquisition of GL Engineering to Globally Expand its Drug Product Fill and Finish Solutions

CAMARILLO, Calif.: CAMARILLO, Calif., Jan. 10, 2022 /PRNewswire/ — SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey. […]

No Picture
News

Continuing push beyond Covid-19 vaccines, Moderna partners with ‘CAR-M’ biotech on in vivo cancer cell therapies

Since coming into a massive windfall with its Covid-19 vaccines, Moderna has been looking for ways to expand its mRNA technologies into other promising areas. On Monday, the biotech took its next step toward that […]

No Picture
News

STAT+: Pharmalittle: Pfizer makes a major push into mRNA technology; Medicare decision on Alzheimer’s drug may hurt state budgets

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so familiar routine of online calls, deadlines, and planning has predictably returned. But what can […]

No Picture
News

New Resource from NCCN Shares Evidence-Based Approaches to Recognize and Manage Graft-Versus-Host Disease after Stem Cell Transplantation

PLYMOUTH MEETING, Pa.: New NCCN Guidelines for Patients: Graft-Versus-Host Disease offers clarity and consensus on how best to address and treat a common and complex immune response side-effect from stem cell transplants. PLYMOUTH MEETING, Pa., […]